These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35460302)

  • 61. Case report: A Chinese child with Andersen-Tawil syndrome due to a de novo KCNJ2 mutation.
    Liu XL; Huang XJ; Luan XH; Zhou HY; Wang T; Wang JY; Shen JY; Chen SD; Tang HD; Cao L
    J Neurol Sci; 2015 May; 352(1-2):105-6. PubMed ID: 25847018
    [No Abstract]   [Full Text] [Related]  

  • 62. Andersen-Tawil syndrome: prospective cohort analysis and expansion of the phenotype.
    Yoon G; Oberoi S; Tristani-Firouzi M; Etheridge SP; Quitania L; Kramer JH; Miller BL; Fu YH; Ptácek LJ
    Am J Med Genet A; 2006 Feb; 140(4):312-21. PubMed ID: 16419128
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Review of the Diagnosis and Treatment of Periodic Paralysis.
    Statland JM; Fontaine B; Hanna MG; Johnson NE; Kissel JT; Sansone VA; Shieh PB; Tawil RN; Trivedi J; Cannon SC; Griggs RC
    Muscle Nerve; 2018 Apr; 57(4):522-530. PubMed ID: 29125635
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and causes a limited form of Andersen-Tawil syndrome.
    Doi T; Makiyama T; Morimoto T; Haruna Y; Tsuji K; Ohno S; Akao M; Takahashi Y; Kimura T; Horie M
    Circ Cardiovasc Genet; 2011 Jun; 4(3):253-60. PubMed ID: 21493816
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Andersen-Tawil syndrome: a review of its clinical and genetic diagnosis with emphasis on cardiac manifestations].
    Márquez MF; Totomoch-Serra A; Vargas-Alarcón G; Cruz-Robles D; Pellizzon OA; Cárdenas M
    Arch Cardiol Mex; 2014; 84(4):278-85. PubMed ID: 25270337
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome.
    Lu CW; Lin JH; Rajawat YS; Jerng H; Rami TG; Sanchez X; DeFreitas G; Carabello B; DeMayo F; Kearney DL; Miller G; Li H; Pfaffinger PJ; Bowles NE; Khoury DS; Towbin JA
    J Med Genet; 2006 Aug; 43(8):653-9. PubMed ID: 16571646
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Andersen-Tawil syndrome. Efficacy of class IC drugs].
    Makarov LM; Komoliatova VN; Kolosov VO; Fedina NN; Solokhin IuA
    Kardiologiia; 2013; 53(1):91-6. PubMed ID: 23548357
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Andersen syndrome: an association of periodic paralysis, cardiac arrhythmia and dysmorphic abnormalities.
    Tengan CH; Antunes AC; Bauab JR; Prado GF; Manzano GM; Gabbai AA
    Arq Neuropsiquiatr; 2006 Sep; 64(3A):582-4. PubMed ID: 17119796
    [TBL] [Abstract][Full Text] [Related]  

  • 69. T75M-KCNJ2 mutation causing Andersen-Tawil syndrome enhances inward rectification by changing Mg2+ sensitivity.
    Tani Y; Miura D; Kurokawa J; Nakamura K; Ouchida M; Shimizu K; Ohe T; Furukawa T
    J Mol Cell Cardiol; 2007 Aug; 43(2):187-96. PubMed ID: 17582433
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ventricular tachyarrhythmias in a patient with Andersen-Tawil syndrome.
    Pyo JY; Joh DH; Park JS; Lee SJ; Lee H; Kim W; Joung B
    Korean Circ J; 2013 Jan; 43(1):62-5. PubMed ID: 23407770
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Severe exacerbation of Andersen-Tawil syndrome secondary to thyrotoxicosis.
    Díaz-Manera J; Querol L; Alejaldre A; Rojas-García R; Ramos-Fransi A; Gallardo E; Illa I
    J Hum Genet; 2014 Aug; 59(8):465-6. PubMed ID: 24849934
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of a novel, dominant negative KCNJ2 mutation associated with Andersen-Tawil syndrome.
    Marrus SB; Cuculich PS; Wang W; Nerbonne JM
    Channels (Austin); 2011; 5(6):500-9. PubMed ID: 22186697
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Short-term response to phenytoin sodium in Andersen-Tawil syndrome-1 with a cardiac-dominant phenotype.
    Rai MK; Pai R; Prabhu MA; Pasha SW; Kedambadi RC; Kamath P; Augustine AJ; Bhavani GS; Girisha KM
    Pacing Clin Electrophysiol; 2019 Feb; 42(2):201-207. PubMed ID: 30516834
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Andersen Tawil syndrome - periodic paralysis with dysmorphism.
    Kamate M; Chetal V
    Indian Pediatr; 2011 Jan; 48(1):64-5. PubMed ID: 21317470
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation.
    Davies NP; Imbrici P; Fialho D; Herd C; Bilsland LG; Weber A; Mueller R; Hilton-Jones D; Ealing J; Boothman BR; Giunti P; Parsons LM; Thomas M; Manzur AY; Jurkat-Rott K; Lehmann-Horn F; Chinnery PF; Rose M; Kullmann DM; Hanna MG
    Neurology; 2005 Oct; 65(7):1083-9. PubMed ID: 16217063
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Electrophysiological mechanisms of ventricular arrhythmias in relation to Andersen-Tawil syndrome under conditions of reduced IK1: a simulation study.
    Sung RJ; Wu SN; Wu JS; Chang HD; Luo CH
    Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2597-605. PubMed ID: 16877549
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Non dominant-negative KCNJ2 gene mutations leading to Andersen-Tawil syndrome with an isolated cardiac phenotype.
    Limberg MM; Zumhagen S; Netter MF; Coffey AJ; Grace A; Rogers J; Böckelmann D; Rinné S; Stallmeyer B; Decher N; Schulze-Bahr E
    Basic Res Cardiol; 2013 May; 108(3):353. PubMed ID: 23644778
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Case report: Mexiletine suppresses ventricular arrhythmias in Andersen-Tawil syndrome.
    Yang J; Li K; Lv T; Xie Y; Liu F; Zhang P
    Front Cardiovasc Med; 2022; 9():992185. PubMed ID: 36093155
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Andersen-Tawil syndrome: Overlapping clinical features with Noonan syndrome?
    van der Werf-'t Lam AS; van Haeringen A; Rinnen T; Robles de Medina RM; Wilde AAM; Hennekam RC; Barge-Schaapveld DQCM
    Eur J Med Genet; 2022 Jan; 65(1):104382. PubMed ID: 34748995
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Role of Nutrition and Physical Activity as Trigger Factors of Paralytic Attacks in Primary Periodic Paralysis.
    Welland NL; Hæstad H; Fossmo HL; Giltvedt K; Ørstavik K; Nordstrøm M
    J Neuromuscul Dis; 2021; 8(4):457-468. PubMed ID: 33646174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.